Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.6%

169 terminated/withdrawn out of 1958 trials

Success Rate

87.9%

+1.4% vs industry average

Late-Stage Pipeline

11%

210 trials in Phase 3/4

Results Transparency

47%

582 of 1228 completed trials have results

Key Signals

235 recruiting582 with results129 terminated40 withdrawn

Enrollment Performance

Analytics

N/A
1023(60.9%)
Phase 2
274(16.3%)
Phase 1
159(9.5%)
Phase 4
126(7.5%)
Phase 3
84(5.0%)
Early Phase 1
13(0.8%)
1679Total
N/A(1023)
Phase 2(274)
Phase 1(159)
Phase 4(126)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1958)

Showing 20 of 1958 trials
NCT07645651Phase 1Not Yet Recruiting

Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer

Role: lead

NCT05681559Not ApplicableCompleted

Investigation of Medical Management to Prevent Episodes of Diverticulitis Trial

Role: lead

NCT07645378Not ApplicableNot Yet Recruiting

Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa

Role: collaborator

NCT07645352Not ApplicableNot Yet Recruiting

Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe

Role: collaborator

NCT07642622Not ApplicableRecruiting

Physical Activity Through Health Technology in Axial Spondyloarthritis

Role: lead

NCT06971978Not ApplicableActive Not Recruiting

Study to Assess the Effectiveness of a Heat Risk Reduction Decision Support Platform and the Barriers and Facilitators of Its Implementation With 30 US Local Health Department Sites

Role: lead

NCT06025747Phase 1Recruiting

A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas

Role: lead

NCT06919614Phase 3Recruiting

STI Testing to Enhance PrEP Use in Pregnancy

Role: collaborator

NCT05968651Phase 2Completed

Social Safety Learning in the Brain Oxytocin System

Role: lead

NCT07060508Phase 2Completed

L9LS in Women of Childbearing Potential in Mali

Role: collaborator

NCT07636434Not ApplicableNot Yet Recruiting

My MS Toolkit: An Internet-Based Depression Self-Management Program for Adults Living With Multiple Sclerosis

Role: lead

NCT07424846Phase 2Recruiting

Xylitol and the Prevention of Periodontal Disease and Preterm Birth Trial

Role: lead

NCT07628140Not ApplicableNot Yet Recruiting

Kulindana: Community-friendly Delivery and Monitoring of TPT to Improve Uptake and Reduce TB Transmission

Role: lead

NCT06392789Not ApplicableCompleted

A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors

Role: lead

NCT07637097Not ApplicableNot Yet Recruiting

VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia

Role: lead

NCT07637110Not ApplicableNot Yet Recruiting

Dry Weight Reduction Intervention Via Extra Ultrafiltration

Role: lead

NCT05899153Not ApplicableRecruiting

Gait Adaptation and Biofeedback for Cerebral Palsy

Role: lead

NCT07332351Phase 2Not Yet Recruiting

Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial

Role: lead

NCT07322341Phase 2Not Yet Recruiting

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

Role: lead

NCT07362433Phase 4Recruiting

Trial of an AI-enabled Digital Stethoscope to Improve Antibiotic Stewardship

Role: collaborator